Skip to Content

R530 (Divalproex sodium delayed-release 250 mg)

Pill imprint R530 has been identified as Divalproex sodium delayed-release 250 mg.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Divalproex sodium delayed-release 250 mg R530
Discount Card Promo
Divalproex sodium delayed-release
Imprint:
R530
Strength:
250 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0530
Inactive Ingredients:
acetone
hypromellose
hypromellose phthalate (31% phthalate, 40 cst)
isopropyl alcohol
methylene chloride
microcrystalline cellulose
povidone
corn starch
silicon dioxide
magnesium silicate
titanium dioxide
vanillin
shellac
ferrosoferric oxide
butyl alcohol
soya lecithin
ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide